Skip to ContentSkip to Navigation
Research Pediatrics
University Medical Center Groningen

New Key Publication: Endogenous glucose production in patients with glycogen storage disease type Ia estimated by oral d-[6,6-2H2]-glucose

10 September 2023

Abstract

Context: Glycogen storage disease type Ia (GSDIa) is an inborn metabolic disorder characterized by impaired endogenous glucose production (EGP). Monitoring of GSDIa patients is prioritized, because of ongoing treatment developments. Stable isotope tracers may enable reliable EGP monitoring.

Objective: The aim of this study was to prospectively assessthe rate of appearance of endogenous glucose into the bloodstream (Ra) in GSDIa patients after a single oral d-[6,6-2H2]-glucose dose.

Design: Ten adult GSDIa patients and ten age-, sex-, BMI-matched healthy volunteers (HV) were enrolled. For each participant, three oral glucose tracer tests were performed: 1) preprandial/fasted, 2) postprandial, and 3) randomly fed states. Dried blood spots were collected before d-[6,6-2H2]-glucose administration and 10, 20, 30, 40, 50, 60, 75, 90, 120 minutes thereafter.

Results: Glucose Ra in fasted HV was consistent with previously reported data. The time-averaged glucose Ra was significantly higher in i) preprandial/fasted GSDIa patients than HV and ii) postprandial HV compared to fasted HV(p<0.05). A progressive decrease in glucose Ra was observed in preprandial/fasted GSDIa patients; the change in glucose Ra time-course was directly correlated with the change in capillary glucose (p<0.05).

Conclusions: This is the first study to quantify glucose Ra in GSDIa patients using oral d-[6,6-2H2] glucose. The test can reliably estimate EGP under conditions in which fasting tolerance is unaffected but does not discriminate between relative contributions of EGP (e.g., liver, kidney) and exogenous sources (e.g., dietary cornstarch). Future application is warranted for longitudinal monitoring after novel genome-based treatments in GSDIa patients in whom nocturnal dietary management can be discontinued.

Authors:

  • Alessandro Rossi
  • Maaike H Oosterveer
  • Theo H van Dijk
  • Aycha Bleeker
  • Martijn Koehorst
  • David A Weinstein
  • Barbara M Bakker
  • Terry G J Derks

Read More: The Journal of Clinical Endocrinology & Metabolism: https://academic.oup.com/jcem/advance-article/doi/10.1210/clinem/dgad537/7266790?login=true

Last modified:11 September 2023 09.49 a.m.
Share this Facebook LinkedIn

More news

  • 06 June 2025

    India-Netherlands Hydrogen Valley Fellowship Programme announced

    To coincide with World Environment Day, 5 June 2025, the Indian Department of Science and Technology and the University of Groningen yesterday announced a Hydrogen Valley Fellowship Programme Partnership, allowing talented Indian scholars working on...

  • 24 March 2025

    UG 28th in World's Most International Universities 2025 rankings

    The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...

  • 05 March 2025

    Women in Science

    The UG celebrates International Women’s Day with a special photo series: Women in Science.